Compounded semaglutide injectable products are at the heart of these concerns. While the FDA says compounded drugs “can serve an important medical need for patients,” the agency does not approve these new formulations, increasing the risk of complications. 

Businesses in the cardiovascular health space have been busy in recent weeks, announcing one big financing round after another. 

Researchers described pharmacies as an “attractive setting for community-based AFib screening."

The American Medical Association has a collection of artifacts on health fraud quackery at its Chicago headquarters office.

Both tirzepatide (Mounjaro) and semaglutide (Ozempic) have made headlines in recent months for their benefits in broad patient populations. This new analysis compared the two medications in obese/overweight adults with and without type 2 diabetes.

“This finding shows great potential to enhance the success of chemotherapy while protecting the heart," one researcher said. 

The new list of discounted drugs includes an anticoagulant, a beta-blocker used to treat atrial fibrillation and much more. 

Teva Pharmaceuticals has officially launched generic liraglutide injections in the United States. Novo Nordisk currently sells liraglutide under the brand name Victoza.